Nosso grupo organiza mais de 3.000 Séries de conferências Eventos todos os anos nos EUA, Europa e outros países. Ásia com o apoio de mais 1.000 Sociedades e publica mais de 700 Acesso aberto Periódicos que contém mais de 50.000 personalidades eminentes, cientistas de renome como membros do conselho editorial.

Periódicos de acesso aberto ganhando mais leitores e citações
700 periódicos e 15 milhões de leitores Cada periódico está obtendo mais de 25.000 leitores

Abstrato

Advancements in Lung Cancer Diagnosis: Innovations and Implications for Early Detection and Personalized Management

Laura Muccillo*

Lung cancer is a devastating disease with high mortality rates worldwide. Early diagnosis plays a critical role in improving patient outcomes and enhancing treatment efficacy. This abstract provides a concise overview of the recent advancements in lung cancer diagnosis, focusing on innovative modalities and biomarkers that have revolutionized early detection and personalized management. The abstract highlights the significance of imaging technologies, molecular biomarkers, and minimally invasive procedures in the early identification of lung cancer. Additionally, it discusses the emerging role of artificial intelligence in refining diagnostic accuracy and the potential future directions in lung cancer diagnosis. This comprehensive review aims to provide healthcare professionals and researchers with a current understanding of the state-of-the-art techniques available to optimize lung cancer diagnosis and treatment planning.